UnitedHealth Group Incorporated (UNH) Stock Forecast & Price Target

UnitedHealth Group Incorporated (UNH) has an ST Score of 59.2 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Analysts rate UNH a Buy, with a price target of $478.00 (+14.0% vs the current price). Our ST Score grades it B- (59.2/100). The ST Score is a data-driven signal, not a recommendation.

Valuation C-, Profitability A-, Financial Strength C+, Momentum C-, Growth C-, Forecast B+, Sentiment A+.

UnitedHealth Group Incorporated (UNH) earns a valuation grade of C-, measured against Medical - Healthcare Plans peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

UnitedHealth Group Incorporated (UNH) earns a growth grade of C-, measured against Medical - Healthcare Plans peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

UnitedHealth Group Incorporated (UNH) earns a profitability grade of A-, measured against Medical - Healthcare Plans peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

UnitedHealth Group Incorporated (UNH) earns a financial strength grade of C+, measured against Medical - Healthcare Plans peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

The average analyst price target for UnitedHealth Group Incorporated (UNH) is $478.00 from 52 analysts, which is +14.0% versus the recent price of $419.26.

UnitedHealth Group Incorporated (UNH) has a Piotroski F-Score of 8 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.